Literature DB >> 8851580

Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.

E Chiari1, A B Oliveira, M A Prado, R J Alves, L M Galvão, F G Araujo.   

Abstract

Since transmission of Chagas' disease by the insect vector is under control in Brazil, transmission by blood transfusion is acquiring special relevance in areas where the disease is endemic and also in countries whose populations are free of infection but that are receiving immigrants from areas where the disease is endemic. Gentian violet, a phenylmethane dye, was the first agent used for the chemical prophylaxis of blood destined for transfusion. A concentration of 0.6 mmol of this dye per liter is effective at eliminating trypomastigotes from blood after 24 h of incubation at 4 degrees C. It is the only effective trypanosomicidal agent available. In the search of alternate compounds, we examined a number of synthetic compounds. They were screened for their activities against blood trypomastigotes of the Y, CL, and B229 strains of Trypanosoma cruzi by using two or more dilutions of each compound. We found that compound Q45, a 6-methoxy-8(diethylaminohexylamino)lepidine dihydrochloride, was highly effective at clearing parasites from infected blood. Doses of 65 and 130 micrograms of this compound eliminated trypomastigotes from blood experimentally contaminated with T. cruzi parasites. These results indicate that Q45 is remarkably active against circulating trypomastigotes. Further studies evaluating Q45 as a prophylactic agent for preventing the transmission of T. cruzi by blood transfusion are of interest.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851580      PMCID: PMC163167     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA.

Authors:  E P CAMARGO
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1964 May-Jun       Impact factor: 1.846

2.  [MORPHOLOGICAL VARIATIONS OBSERVED IN DIFFERENT STRAINS OF TRYPANOSOMA CRUZI].

Authors:  Z BRENER; E CHIARI
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1963 Sep-Oct       Impact factor: 1.846

3.  [Effect of gentian violet on Trypanosoma cruzi in vitro; importance in the sterilization of blood for transfusion].

Authors:  V NUSSENZWEIG; A BIANCALANA; V AMATO NETO; R SONNTAG; J P DE FREITAS; J KLOETZEL
Journal:  Rev Paul Med       Date:  1953-01

4.  In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii.

Authors:  F G Araujo; J Huskinson-Mark; W E Gutteridge; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

5.  Screening in vitro of natural products against blood forms of Trypanosoma cruzi.

Authors:  E Chiari; A B de Oliveira; D S Raslan; A A Mesquita; K G Tavares
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 May-Jun       Impact factor: 2.184

6.  Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.

Authors:  F G Araujo; J Huskinson; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

7.  Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes.

Authors:  M Carneiro; A J Romanha; E Chiari
Journal:  Mem Inst Oswaldo Cruz       Date:  1991 Oct-Dec       Impact factor: 2.743

8.  Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California.

Authors:  P R Kerndt; H A Waskin; L V Kirchhoff; F Steurer; S H Waterman; J M Nelson; G A Gellert; I A Shulman
Journal:  Transfusion       Date:  1991 Nov-Dec       Impact factor: 3.157

9.  Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis.

Authors:  J A Sherwood; G S Gachihi; R K Muigai; D R Skillman; M Mugo; J R Rashid; K M Wasunna; J B Were; S K Kasili; J M Mbugua
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

10.  [The evaluation of ketoconazole in mice inoculated with Paracoccidioides brasiliensis by liver and spleen histopathology and by the intradermal paracoccidioidin reaction].

Authors:  M R Silva; L F de Paiva e Rosália; S A Jesuino
Journal:  Rev Soc Bras Med Trop       Date:  1994 Jan-Mar       Impact factor: 1.581

View more
  6 in total

1.  Trypanocidal activity and acute toxicity assessment of triterpene acids.

Authors:  Daniele da Silva Ferreira; Viviane Rodrigues Esperandim; Miriam Paula Alonso Toldo; Juliana Saraiva; Wilson Roberto Cunha; Sérgio de Albuquerque
Journal:  Parasitol Res       Date:  2010-02-06       Impact factor: 2.289

2.  Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine.

Authors:  Vanessa Yardley; Francisco Gamarro; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

3.  In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.

Authors:  J J N Silva; A L Osakabe; W R Pavanelli; J S Silva; D W Franco
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

4.  Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones.

Authors:  Solange L de Castro; Denise G J Batista; Marcos M Batista; Wanderson Batista; Anissa Daliry; Elen M de Souza; Rubem F S Menna-Barreto; Gabriel M Oliveira; Kelly Salomão; Cristiane F Silva; Patricia B Silva; Maria de Nazaré C Soeiro
Journal:  Mol Biol Int       Date:  2011-06-30

5.  Synthesis and docking analysis of new heterocyclic system of tetrazolo[5',1':2,3][1,3,4]thiadiazepino [7,6-b]quinolines as aldose reductase inhibitors.

Authors:  Mohammad Saadatmandzadeh; Mohammad Rahimizadeh; Hossein Eshghi; Mojtaba Sankian
Journal:  Iran J Basic Med Sci       Date:  2014-09       Impact factor: 2.699

6.  Transition metal complexes of quinolino[3,2-b]benzodiazepine and quinolino[3,2-b]benzoxazepine: synthesis, characterization, and antimicrobial studies.

Authors:  B Basavaraju; Halehatty S Bhojya Naik; Mustur C Prabhakara
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.